| Dermatitis |
1 |
1 |
| Otolaryngology |
0 |
0.95 |
| Child |
0 |
0.98 |
| Pain Management |
0 |
0.67 |
| Atopic Dermatitis |
0 |
0.99 |
| Upper Respiratory Tract Infection |
0 |
0.28 |
| Pruritus |
0 |
0.19 |
| Respiratory Tract |
0 |
0.19 |
| Psoriasis |
0 |
0.18 |
| Patient Safety |
0 |
0.14 |
| Pediatric Dermatology |
0 |
0.97 |
| Topical Corticosteroid |
0 |
0.14 |
| Adverse Effects |
0 |
0.1 |
| Calcineurin Inhibitor |
0 |
0.1 |
| California |
0 |
0.1 |
| Cellulitis |
0 |
0.1 |
| Connecticut |
0 |
0.1 |
| Corticosteroids |
0 |
0.1 |
| Eczema |
0 |
0.1 |
| Food and Drug Administration (FDA) |
0 |
0.1 |
| Hospital |
0 |
0.1 |
| Pain |
0 |
0.1 |
| Severity Index |
0 |
0.1 |
| Acute Bacterial Skin Infections |
0 |
0.09 |
| Antibiotics |
0 |
0.09 |
| Skin and Soft Tissue Infection |
0 |
0.09 |